Ballentine Partners, LLC Viatris Inc Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q4 2024
A detailed history of Ballentine Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 20,582 shares of VTRS stock, worth $230,518. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,582
Previous 18,511
11.19%
Holding current value
$230,518
Previous $214,000
19.63%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,091Shares Held
966MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.58 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.04 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$707 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$702 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$546 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...